The plain-language read
Topical retinoids (tretinoin, retinaldehyde, retinol) remain the gold standard for treating photodamage. This systematic review covers 50 years of clinical evidence demonstrating retinoids increase epidermal turnover, normalize follicular keratinization, stimulate dermal collagen synthesis, and reduce hyperpigmentation. Tretinoin 0.
- Tretinoin remains the most robustly evidenced retinoid for photoaging
- Visible improvement appears at 12 weeks; full benefit at 24+ weeks
- Retinaldehyde and retinol convert to retinoic acid in skin at lower potency
- Side effects (erythema, scaling) are dose-dependent and habituable
Retinoids belong in nearly every long-term anti-aging protocol. Start low (retinol 0.3% or retinaldehyde 0.05%), titrate frequency before strength, and pair with a ceramide-rich moisturizer to manage barrier disruption.
What this means for your routine
If you're targeting photoaging, this research supports adding retinol to your PM routine. Effective concentration range: 0.025–0.1% based on this study. Timeline to expect: 12 weeks based on study duration.
If you're targeting photoaging, this research supports adding tretinoin to your PM routine. Effective concentration range: 0.025–0.1% based on this study. Timeline to expect: 12 weeks based on study duration.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
A systematic review of 50 years of retinoid literature confirms that tretinoin 0.025–0.1% produces statistically significant improvements in fine lines, mottled pigmentation, and tactile roughness at 12+ weeks. Mechanisms include increased epidermal proliferation, normalized follicular keratinization, dermal collagen I/III synthesis upregulation, and inhibition of melanosome transfer.
Full abstract→
Topical retinoids (tretinoin, retinaldehyde, retinol) remain the gold standard for treating photodamage. This systematic review covers 50 years of clinical evidence demonstrating retinoids increase epidermal turnover, normalize follicular keratinization, stimulate dermal collagen synthesis, and reduce hyperpigmentation. Tretinoin 0.025–0.1% has the strongest evidence base, with measurable improvement in fine lines, mottled pigmentation, and roughness from 12 weeks onward.
Original source →Does Astragalus mongholicus Bunge help promote the healing of wounds? A systematic review and meta-analysis of preclinical animal studies.
Wounds continue to represent a significant public health challenge globally. In recent years, Astragalus mongholicus Bunge, a traditional Chinese botanical drug utilized for wound treatment, has garnered increasing research attention. However, the therapeutic efficacy and safety of this natural botanical drug on wound healing remain poorly understood.
Sunscreen use and the prevention of photoaging: a 4.5-year randomized controlled trial
A 4.5-year RCT showed daily SPF 15 reduces skin aging by 24% measured objectively. There is no anti-aging serum with this evidence base. Daily SPF is the single highest-leverage intervention.
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
L-Carnitine, an amino acid derivative critical for fatty acid metabolism, exhibits anti-inflammatory, antioxidant, and cytoprotective properties, with emerging applications in dermatology. This review explores its therapeutic potential, both topically and systemically, and its role as a biomarker in various skin disorders. A systematic search of Medline, EMBASE, and PubMed (1946-January 2025) was conducted, focusing on L-carnitine and dermatologic conditions, excluding acetyltransferases, acyltransferases, breast, and genetic metabolic diseases.